Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Acta Oncologica (Stockholm, Sweden)|October 10, 2015
A five-factor biomarker profile obtained week 4-12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2Anne V Soerensen, Poul F Geertsen, Ib J Christensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2022
External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell CancerBhavna Oza, Tim Eisen, Eleni Frangou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup TrialTim Eisen, Eleni Frangou, Bhavna Oza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2018
Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk GroupsKim E M van Kessel, Kirstin A van der Keur, Lars Dyrskjøt, et al.
Nature Genetics|January 3, 2025
Comprehensive genomic characterization of early-stage bladder cancerFrederik Prip, Philippe Lamy, Sia Viborg Lindskrog, et al.
Cancer Cell|June 21, 2016
Comprehensive Transcriptional Analysis of Early-Stage Urothelial CarcinomaJakob Hedegaard, Philippe Lamy, Iver Nordentoft, et al.
Nature Communications|April 17, 2021
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia Viborg Lindskrog, Frederik Prip, Philippe Lamy, et al.
Pageof 3